| Distinct and overlapping functional zones in the cerebellum defined by resting state functional connectivity JX O'reilly, CF Beckmann, V Tomassini, N Ramnani, H Johansen-Berg Cerebral cortex 20 (4), 953-965, 2010 | 774 | 2010 |
| Age-related changes in grey and white matter structure throughout adulthood A Giorgio, L Santelli, V Tomassini, R Bosnell, S Smith, N De Stefano, ... Neuroimage 51 (3), 943-951, 2010 | 593 | 2010 |
| Diffusion-weighted imaging tractography-based parcellation of the human parietal cortex and comparison with human and macaque resting-state functional connectivity RB Mars, S Jbabdi, J Sallet, JX O'Reilly, PL Croxson, E Olivier, ... Journal of Neuroscience 31 (11), 4087-4100, 2011 | 502 | 2011 |
| Diffusion-weighted imaging tractography-based parcellation of the human lateral premotor cortex identifies dorsal and ventral subregions with anatomical and functional … V Tomassini, S Jbabdi, JC Klein, TEJ Behrens, C Pozzilli, PM Matthews, ... Journal of Neuroscience 27 (38), 10259-10269, 2007 | 355 | 2007 |
| Clinical outcomes of escalation vs early intensive disease-modifying therapy in patients with multiple sclerosis K Harding, O Williams, M Willis, J Hrastelj, A Rimmer, F Joseph, ... JAMA neurology 76 (5), 536-541, 2019 | 263 | 2019 |
| Neurological update: MOG antibody disease R Wynford-Thomas, A Jacob, V Tomassini Journal of neurology 266, 1280-1286, 2019 | 241 | 2019 |
| Comparison of the effects of acetyl L-carnitine and amantadine for the treatment of fatigue in multiple sclerosis: results of a pilot, randomised, double-blind, crossover trial V Tomassini, C Pozzilli, E Onesti, P Pasqualetti, F Marinelli, A Pisani, ... Journal of the neurological sciences 218 (1-2), 103-108, 2004 | 195 | 2004 |
| Sex hormones modulate brain damage in multiple sclerosis: MRI evidence V Tomassini, E Onesti, C Mainero, E Giugni, A Paolillo, M Salvetti, ... Journal of Neurology, Neurosurgery & Psychiatry 76 (2), 272-275, 2005 | 193 | 2005 |
| Structural and functional bases for individual differences in motor learning V Tomassini, S Jbabdi, ZT Kincses, R Bosnell, G Douaud, C Pozzilli, ... Human brain mapping 32 (3), 494-508, 2011 | 181 | 2011 |
| Neuroplasticity and functional recovery in multiple sclerosis V Tomassini, PM Matthews, AJ Thompson, D Fuglø, JJ Geurts, ... Nature Reviews Neurology 8 (11), 635-646, 2012 | 179 | 2012 |
| ‘Gender gap’in multiple sclerosis: magnetic resonance imaging evidence C Pozzilli, V Tomassini, F Marinelli, A Paolillo, C Gasperini, S Bastianello European journal of neurology 10 (1), 95-97, 2003 | 175 | 2003 |
| Brain atrophy in relapsing-remitting multiple sclerosis: relationship with ‘black holes’, disease duration and clinical disability A Paolillo, C Pozzilli, C Gasperini, E Giugni, C Mainero, S Giuliani, ... Journal of the neurological sciences 174 (2), 85-91, 2000 | 163 | 2000 |
| Targeting ASIC1 in primary progressive multiple sclerosis: evidence of neuroprotection with amiloride T Arun, V Tomassini, E Sbardella, MB De Ruiter, L Matthews, MI Leite, ... Brain 136 (1), 106-115, 2013 | 152 | 2013 |
| The effect of hypointense white matter lesions on automated gray matter segmentation in multiple sclerosis R Gelineau‐Morel, V Tomassini, M Jenkinson, H Johansen‐Berg, ... Human brain mapping 33 (12), 2802-2814, 2012 | 148 | 2012 |
| Predictors of long–term clinical response to interferon beta therapy in relapsing multiple sclerosis V Tomassini, A Paolillo, P Russo, E Giugni, L Prosperini, C Gasperini, ... Journal of neurology 253, 287-293, 2006 | 142 | 2006 |
| Psychopathological and cognitive effects of therapeutic cannabinoids in multiple sclerosis: a double-blind, placebo controlled, crossover study M Aragona, E Onesti, V Tomassini, A Conte, S Gupta, F Gilio, P Pantano, ... Clinical neuropharmacology 32 (1), 41-47, 2009 | 128 | 2009 |
| Model-free characterization of brain functional networks for motor sequence learning using fMRI ZT Kincses, H Johansen-Berg, V Tomassini, R Bosnell, PM Matthews, ... Neuroimage 39 (4), 1950-1958, 2008 | 127 | 2008 |
| Serum MMP-9/TIMP-1 and MMP-2/TIMP-2 ratios in multiple sclerosis: relationships with different magnetic resonance imaging measures of disease activity during IFN-beta-1a treatment C Avolio, M Filippi, C Tortorella, MA Rocca, M Ruggieri, F Agosta, ... Multiple Sclerosis Journal 11 (4), 441-446, 2005 | 111 | 2005 |
| DMTs and Covid‐19 severity in MS: a pooled analysis from Italy and France MP Sormani, M Salvetti, P Labauge, I Schiavetti, H Zephir, L Carmisciano, ... Annals of clinical and translational neurology 8 (8), 1738-1744, 2021 | 104 | 2021 |
| Monthly corticosteroids decrease neutralizing antibodies to IFNβ1b: a randomized trial in multiple sclerosis C Pozzilli, G Antonini, F Bagnato, C Mainero, V Tomassini, E Onesti, ... Journal of neurology 249, 50-56, 2002 | 104 | 2002 |
Carlo PozzilliSapienza University of RomeVerified email at uniroma1.it
